These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11229859)

  • 1. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia.
    Yolken RH; Bachmann S; Ruslanova I; Lillehoj E; Ford G; Torrey EF; Schroeder J
    Clin Infect Dis; 2001 Mar; 32(5):842-4. PubMed ID: 11229859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasma gondii infection in first-episode and inpatient individuals with schizophrenia.
    Hamidinejat H; Ghorbanpoor M; Hosseini H; Alavi SM; Nabavi L; Jalali MH; Borojeni MP; Jafari H; Mohammadaligol S
    Int J Infect Dis; 2010 Nov; 14(11):e978-81. PubMed ID: 20843718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The schizophrenia and Toxoplasma gondii connection: infectious, immune or both?
    Tamer GS; Dundar D; Yalug I; Caliskan S; Yazar S; Aker A
    Adv Ther; 2008 Jul; 25(7):703-9. PubMed ID: 18563312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to infectious agents in individuals with recent onset schizophrenia.
    Leweke FM; Gerth CW; Koethe D; Klosterkötter J; Ruslanova I; Krivogorsky B; Torrey EF; Yolken RH
    Eur Arch Psychiatry Clin Neurosci; 2004 Feb; 254(1):4-8. PubMed ID: 14991372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selected infectious agents and risk of schizophrenia among U.S. military personnel.
    Niebuhr DW; Millikan AM; Cowan DN; Yolken R; Li Y; Weber NS
    Am J Psychiatry; 2008 Jan; 165(1):99-106. PubMed ID: 18086751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia.
    Wang HL; Wang GH; Li QY; Shu C; Jiang MS; Guo Y
    Acta Psychiatr Scand; 2006 Jul; 114(1):40-8. PubMed ID: 16774660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Toxoplasma gondii antibodies in patients with schizophrenia--preliminary findings in a Turkish sample.
    Cetinkaya Z; Yazar S; Gecici O; Namli MN
    Schizophr Bull; 2007 May; 33(3):789-91. PubMed ID: 17404388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasma gondii IgM antibody prevalence study in patients suffering from neurological disorders.
    Shanmugam J; Naseema K; Sarada C; Rout D
    Indian J Pathol Microbiol; 1995 Oct; 38(4):423-6. PubMed ID: 9726156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopathology in first-episode schizophrenia and antibodies to Toxoplasma gondii.
    Bachmann S; Schröder J; Bottmer C; Torrey EF; Yolken RH
    Psychopathology; 2005; 38(2):87-90. PubMed ID: 15855832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Problems and limitations of conventional and innovative methods for the diagnosis of Toxoplasmosis in humans and animals].
    Piergili Fioretti D
    Parassitologia; 2004 Jun; 46(1-2):177-81. PubMed ID: 15305712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the usefulness examination of IgG avidity for serodiagnosis of toxoplasmosis].
    Sobieszczańska BM
    Pol Merkur Lekarski; 2002 Aug; 13(74):111-5. PubMed ID: 12420339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxoplasma and schizophrenia.
    Yolken RH; Dickerson FB; Fuller Torrey E
    Parasite Immunol; 2009 Nov; 31(11):706-15. PubMed ID: 19825110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenia and serological methods for diagnosis of toxoplasmosis.
    Derouin F; Thulliez P; Romand S
    Clin Infect Dis; 2002 Jan; 34(1):127-9. PubMed ID: 11731958
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-Toxoplasma gondii antibodies in hemodialysis patients receiving long-term hemodialysis therapy in Turkey.
    Ocak S; Duran N; Eskiocak AF; Aytac H
    Saudi Med J; 2005 Sep; 26(9):1378-82. PubMed ID: 16155651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiological study of toxoplasmosis in different sections of population of Union Territory of Chandigarh.
    Mohan B; Dubey ML; Malla N; Kumar R
    J Commun Dis; 2002 Mar; 34(1):15-22. PubMed ID: 12718337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a commercial enzyme immunoassay and an immunoblot technique for detection of immunoglobulin A antibodies to Toxoplasma gondii.
    Gross U; Bohne W; Schröder J; Roos T; Heesemann J
    Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):636-9. PubMed ID: 8223666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the immunoglobulin G avidity and enzyme immunoassay IgG/IgM screening tests for differentiation of the clinical spectrum of toxoplasmosis.
    Tanyuksel M; Guney C; Araz E; Saracli MA; Doganci L
    J Microbiol; 2004 Sep; 42(3):211-5. PubMed ID: 15459650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensorineural hearing loss due to Toxoplasma gondii in children: a case-control study.
    Noorbakhsh S; Memari F; Farhadi M; Tabatabaei A
    Clin Otolaryngol; 2008 Jun; 33(3):269-73. PubMed ID: 18559038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxoplasma gondii antibodies in cancer patients.
    Yuan Z; Gao S; Liu Q; Xia X; Liu X; Liu B; Hu R
    Cancer Lett; 2007 Aug; 254(1):71-4. PubMed ID: 17376590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasmosis: antitoxoplasma IgG antibody levels in patients with lymphoid neoplasia in Ibadan, Nigeria.
    Ekweozor CC; Okpala LE; Bamgboye AE; Jegede O
    Afr J Med Med Sci; 1994 Dec; 23(4):347-53. PubMed ID: 7653402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.